LEANNA ORNDORFF: Open Payments
NPI 1760192579 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,140 in 55 payments from 18 companies in 2025. Trend: 2023 $958 · 2024 $1,471 · 2025 $1,140
Food & beverage: $1,140
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $248 |
| Sumitomo Pharma America, Inc. | 5 | $123 |
| PFIZER INC. | 6 | $115 |
| GlaxoSmithKline, LLC. | 6 | $112 |
| ABBVIE INC. | 5 | $101 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Lilly USA, LLC | 3 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $49 |
| Amgen Inc. | 3 | $49 |
| Amneal Pharmaceuticals LLC | 2 | $34 |
Products named: Ozempic, GEMTESA, SHINGRIX, MOUNJARO, Wegovy, XIFAXAN, EVENITY, PREVNAR 20.
Industry payments across NC — which companies pay providers there.
